The Oncology Brothers Highlight Three Studies from AACR 2023

By Oncology Brothers - Last Updated: May 1, 2023

The Oncology Brothers highlight three studies from the recent American Association for Cancer Research (AACR) 2023 Annual Meeting, each centered around a different disease site. In this segment, they detail: The AEGAN study, which focused on resectable, non-small cell lung cancer patients; the KEYNOTE-966 study, a Phase III trial on patients with unresectable, locally advanced extrahepatic or intrahepatic cholangiocarcinoma or gallbladder cancer; and the SWOG S1512, a study on desmoplastic melanoma, which the duo noted as having “encouraging” results. All three studies have the potential to impact the oncology community setting.

Advertisement
Advertisement
Latest News

June 2, 2023